Health ❯ Public Health ❯ Chronic Diseases

Hypertension

Management Strategies Cognitive Health Dementia Heart Disease Dementia Risk Reduction Prevalence Awareness Campaigns Prevention and Control Management Programs Cardiovascular Events

FDA Approves AstraZeneca’s Baxfendy for Hard-to-Control Hypertension

The oral aldosterone‑blocking pill showed near double‑digit drops in systolic pressure in late‑stage testing.

Global Study Finds 1.7 Billion Adults Have Hypertension as Control Lags in Poorer Countries

Hypertension Rates Climb in Peru, Mexico and Argentina as Warnings Intensify

Study Finds Nearly Half of Post‑9/11 Veterans Have Hypertension, Many Cases Undiagnosed

Indian Experts Urge Nationwide Shift to Potassium-Enriched Low-Sodium Salt

Mexico’s 50+ Population Reaches 32 Million as Diabetes and Hypertension Rise, Reported Access Falls

PAC Presses MoD After Data Shows Lower Lifestyle Disease Rates in Army JCOs/OR

Study Finds Nearly a Quarter of UK Soups Breach Salt Targets

Beige Fat Shields Arteries as PRDM16 Loss Drives QSOX1 and High Blood Pressure

Hydralazine Identified as ADO Inhibitor, Putting Glioblastoma Cells Into Senescence in Lab Study

New WHO Report Flags 1.4 Billion Living With Hypertension as Control Rates Lag Worldwide

Brazil Reclassifies Blood Pressure to Label 12/8 as Pre‑Hypertension

AHA and AMA Honor 2,307 Health Organizations for Blood Pressure Control Through Target: BP

U.S. Deaths From Hypertensive Kidney Disease Up 48% Since 1999, Study Finds

Salt Substitute Use Remains Rare in U.S., AHA Analysis Finds

AHA Lowers Blood Pressure Target as Lancet Study Debuts Tool to Tailor Treatment

Lancet Study Debuts Calculator to Match Hypertension Drugs to Needed BP Reductions

Cambridge Researchers Pinpoint Why Arm Cuff Tests Underestimate Systolic Blood Pressure

Blood Pressure Risks Rise During Polar Wave as Sonora Sees Sodium-Driven Hypertension Surge

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension